Tesa out the game? CBL-514 the new Tesa

CBL-514 is a novel injectable drug that may be safe and efficacious for localized abdominal subcutaneous fat reduction
Would love to see articles/links about this. Yes, I know Google exists, but I'd be more curious to see the things you've read about instead of Google's cold robot heart algorithm, haha.

Not sure Tesa/Egrifta is going away though. Looks like you said CBL-514 does its work on subcutaneous fat, Tesa drops the hammer on visceral fat. Not sure if combining them would have any high risks associated with it, but together, one could quickly look like a Fallout style Ghoul, I bet!
 
CBL-514 is a novel injectable drug that may be safe and efficacious for localized abdominal subcutaneous fat reduction

Can you elaborate on the safe part? The 3 sides I worry about with starting Tesa is edema and raising cortisol and prolactin.

The FDA are sure going to have their hands full when they get ready to ban all peptides because I am pretty sure they are going to have to do it one compound at a time. I don't think they can just blanket ban every compound on the planet or ever synthesized. I sure hope not. Science needs to invent thousands, maybe millions of new peptides with only enough changes in the structure to make it a unique compound, but with similar effects.

Should just take a few tech bro scientists with AI to start cranking out millions of new peptides every day and send these FDA luddites back to their cave.
 
Last edited:
Is CBL-514 even available to buy yet? I obviously mean grey, not big pharma.
 
Is CBL-514 even available to buy yet? I obviously mean grey, not big pharma.

I just started researching it after reading this post. But I can just guess, if it is not, then it will be soon enough. I'm really interested in the safety profile if it is similar to the 'morelin' class type peptides.
 
It’s not a peptide though. Small molecule. Harder to come by.
 
Is CBL-514 even available to buy yet? I obviously mean grey, not big pharma.
"It is a proprietary small-molecule drug currently in Phase 3 clinical trials and owned exclusively by Caliway Biopharmaceuticals, a publicly traded company based in Taiwan (TWSE: 6919)"

Close enough to our sources 😉
 

Trending Topics

Forum Statistics

Threads
17,717
Posts
183,926
Members
59,529
Newest
roddyypaul
Back
Top Bottom